BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 17880194)

  • 1. y-Randomization and its variants in QSPR/QSAR.
    Rücker C; Rücker G; Meringer M
    J Chem Inf Model; 2007; 47(6):2345-57. PubMed ID: 17880194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative structure-activity relationship modeling of juvenile hormone mimetic compounds for Culex pipiens larvae, with a discussion of descriptor-thinning methods.
    Basak SC; Natarajan R; Mills D; Hawkins DM; Kraker JJ
    J Chem Inf Model; 2006; 46(1):65-77. PubMed ID: 16426041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Legitimate utilization of large descriptor pools for QSPR/QSAR models.
    Katritzky AR; Dobchev DA; Slavov S; Karelson M
    J Chem Inf Model; 2008 Nov; 48(11):2207-13. PubMed ID: 18956833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combinatorial QSAR modeling of P-glycoprotein substrates.
    de Cerqueira Lima P; Golbraikh A; Oloff S; Xiao Y; Tropsha A
    J Chem Inf Model; 2006; 46(3):1245-54. PubMed ID: 16711744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction and mechanistic interpretation of human oral drug absorption using MI-QSAR analysis.
    Iyer M; Tseng YJ; Senese CL; Liu J; Hopfinger AJ
    Mol Pharm; 2007; 4(2):218-31. PubMed ID: 17397237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stochastic versus stepwise strategies for quantitative structure-activity relationship generation--how much effort may the mining for successful QSAR models take?
    Horvath D; Bonachera F; Solov'ev V; Gaudin C; Varnek A
    J Chem Inf Model; 2007; 47(3):927-39. PubMed ID: 17480052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QSAR modeling of human serum protein binding with several modeling techniques utilizing structure-information representation.
    Votano JR; Parham M; Hall LM; Hall LH; Kier LB; Oloff S; Tropsha A
    J Med Chem; 2006 Nov; 49(24):7169-81. PubMed ID: 17125269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective descriptor pruning for QSAR/QSPR studies using artificial neural networks.
    Turner JV; Cutler DJ; Spence I; Maddalena DJ
    J Comput Chem; 2003 May; 24(7):891-7. PubMed ID: 12692798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interpreting computational neural network QSAR models: a measure of descriptor importance.
    Guha R; Jurs PC
    J Chem Inf Model; 2005; 45(3):800-6. PubMed ID: 15921469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
    Baert B; Deconinck E; Van Gele M; Slodicka M; Stoppie P; Bodé S; Slegers G; Vander Heyden Y; Lambert J; Beetens J; De Spiegeleer B
    Bioorg Med Chem; 2007 Nov; 15(22):6943-55. PubMed ID: 17827020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The signature molecular descriptor. 1. Using extended valence sequences in QSAR and QSPR studies.
    Faulon JL; Visco DP; Pophale RS
    J Chem Inf Comput Sci; 2003; 43(3):707-20. PubMed ID: 12767129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico ADME modelling 2: computational models to predict human serum albumin binding affinity using ant colony systems.
    Gunturi SB; Narayanan R; Khandelwal A
    Bioorg Med Chem; 2006 Jun; 14(12):4118-29. PubMed ID: 16504519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of random forest approach to QSAR prediction of aquatic toxicity.
    Polishchuk PG; Muratov EN; Artemenko AG; Kolumbin OG; Muratov NN; Kuz'min VE
    J Chem Inf Model; 2009 Nov; 49(11):2481-8. PubMed ID: 19860412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QSPR models for half-wave reduction potential of steroids: a comparative study between feature selection and feature extraction from subsets of or entire set of descriptors.
    Hemmateenejad B; Yazdani M
    Anal Chim Acta; 2009 Feb; 634(1):27-35. PubMed ID: 19154806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative structure-retention relationship for the Kovats retention indices of a large set of terpenes: a combined data splitting-feature selection strategy.
    Hemmateenejad B; Javadnia K; Elyasi M
    Anal Chim Acta; 2007 May; 592(1):72-81. PubMed ID: 17499073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QSAR--how good is it in practice? Comparison of descriptor sets on an unbiased cross section of corporate data sets.
    Gedeck P; Rohde B; Bartels C
    J Chem Inf Model; 2006; 46(5):1924-36. PubMed ID: 16995723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. kappa Nearest neighbors QSAR modeling as a variational problem: theory and applications.
    Itskowitz P; Tropsha A
    J Chem Inf Model; 2005; 45(3):777-85. PubMed ID: 15921467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, inhibitory activities, and QSAR study of xanthone derivatives as alpha-glucosidase inhibitors.
    Liu Y; Ke Z; Cui J; Chen WH; Ma L; Wang B
    Bioorg Med Chem; 2008 Aug; 16(15):7185-92. PubMed ID: 18632275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A quantitative structure property relationship for prediction of solubilization of hazardous compounds using GA-based MLR in CTAB micellar media.
    Ghasemi JB; Abdolmaleki A; Mandoumi N
    J Hazard Mater; 2009 Jan; 161(1):74-80. PubMed ID: 18456399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecule kernels: a descriptor- and alignment-free quantitative structure-activity relationship approach.
    Mohr JA; Jain BJ; Obermayer K
    J Chem Inf Model; 2008 Sep; 48(9):1868-81. PubMed ID: 18767832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.